Humble's DRM-Freedom Sale Discounts Broforce, Surgeon Simulator, and More

The Humble Store's new sale donates 10 percent of your purchase to charity.

Comments

Related
Broforce
Follow
Machinarium
Follow
Retro City Rampage
Follow
No Caption Provided

The Humble Store today kicked off its Independence Day sale--the DRM-Freedom sale--which will run for the next two weeks and offer discounts up to 85 percent off of a variety of games.

A selection of new deals will be rotated in every 24 hours throughout the sale. Today's deals include the early access version of co-op shooter Broforce for $10 (regularly $15); the always-wacky Surgeon Simulator 2013 for $2.50 (regularly $10); gorgeous, hand-drawn adventure game Machinarium for $2 (regularly $10); and puzzle/RPG hybrid Dungeon Hearts for a mere $0.44 (regularly $3).

As the name of the sale suggests, all games are available free of DRM--meaning you don't need to worry about using a third-party client or verifying that you're online in order to play any of them. Many of the games also include access to the Steam versions if, like me, you prefer to be plugged into that system whenever possible while playing PC games.

After the recent Steam and GOG summer sales, you might be feeling guilty about adding even more games to your PC backlog, but the Humble Store provides a great excuse to do so: ten percent of all Humble Store purchases go toward charities including the American Red Cross and Child's Play. We recently learned that, since the online store's launch last November, $1 million has been raised for charity. This is in addition to all of the money raised during the always-popular Humble Bundles.

The full list of today's deals:

The DRM-Freedom sale runs from today through Wednesday, July 16 at 10AM Pacific.

Is there anything you plan on picking up? Perhaps more importantly, do you have any money left after the Steam and GOG sales? Let us know in the comments below.

Got a news tip or want to contact us directly? Email news@gamespot.com

  •   View Comments (0)
    Join the conversation
    There are no comments about this story